Evidence map›Paper›PMID 30648929›Full record

ArticleThyroid : official journal of the American Thyroid Association2019

GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.

Marina N Nikiforova, Alyaksandr V Nikitski, Federica Panebianco, Cihan Kaya, Linwah Yip, Michelle Williams, Simion I Chiosea, Raja R Seethala, Somak Roy, Vincenzo Condello and 6 more

Open access · greenAbstract read
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Follicular adenoma of the thyroid with hyalinizing trabecular tumor-like pattern.Virchows Archiv : an international journal of pathology · 2026
    Article
  3. Article
  4. Article
  5. Thyroid cytology: practical tricks and pitfalls.Virchows Archiv : an international journal of pathology · 2026
    Review
  6. Review
  7. Article
  8. Spindle lesions in the thyroid: a cytological and histological review.Virchows Archiv : an international journal of pathology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Progress in Thyroid Cancer Genomics: A 40-Year Journey.Thyroid : official journal of the American Thyroid Association · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Total thyroidectomy can still remain the method of choice in some Bethesda III cases.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Marina N Nikiforova1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Alyaksandr V Nikitski1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Federica Panebianco1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Cihan Kaya1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Linwah Yip2 Division of Endocrine Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Michelle Williams3 Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Simion I Chiosea1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Raja R Seethala1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Somak Roy1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Vincenzo Condello1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Lucas Santana-Santos1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Abigail I Wald1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Sally E Carty2 Division of Endocrine Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Robert L Ferris4 UPMC Hillman Cancer Center, UPMC Cancer Pavilion, Pittsburgh, Pennsylvania.
Adel K El-Naggar3 Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Yuri E Nikiforov1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
University of Pittsburgh Medical Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHNP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 2004 to 2026
$49.6M
ALK Rearrangements in Aggressive Thyroid CancerR01CA181150 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NIKIFOROV, YURI E · 2014 to 2024
$3.3M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA097190NCI NIH HHS R01 CA181150
6 · The paper itself

Abstract

backgroundHyalinizing trabecular tumor (HTT) is a rare thyroid neoplasm with a characteristic trabecular growth pattern and hyalinization. This lesion has been the subject of long-term controversy surrounding its genetic mechanisms, relationship to papillary thyroid carcinoma (PTC), and malignant potential. Due to the presence of nuclear features shared with PTC, HTT frequently contributes to a false-positive cytology, which hampers patient management. The goal of this study was to apply genome-wide sequencing analyses to elucidate the genetic mechanisms of HTT and its relationship to PTC.

methodsWhole-exome, RNA-Seq, and targeted next-generation sequencing analyses were performed to discover and characterize driver mutations in HTT. RNA-Seq results were used for pathway analysis. Tissue expression of GLIS3 and other proteins was detected by immunohistochemistry. The prevalence of GLIS fusions was studied in 17 tumors initially diagnosed as HTT, 220 PTC, and 10,165 thyroid fine-needle aspiration samples.

resultsUsing whole-exome and RNA-Seq analyses of the initial three HTT, no known thyroid tumor mutations were identified, while in-frame gene fusion between PAX8 exon 2 and GLIS3 exon 3 was detected in all tumors. Further analysis identified PAX8-GLIS3 in 13/14 (93%) and PAX8-GLIS1 in 1/14 (7%) of HTT confirmed after blind pathology review. The fusions were validated by Sanger sequencing and FISH. The fusions resulted in overexpression of the 3'-portion of GLIS3 and GLIS1 mRNA containing intact DNA-binding domains of these transcription factors and upregulation of extracellular matrix genes including collagen IV. Immunohistochemistry confirmed upregulation and deposition of collagen IV and pan-collagen in HTT. The analysis of 220 PTC revealed no PAX8-GLIS3 and one PAX8-GLIS1 fusion. PAX8-GLIS3 was prospectively identified in 8/10,165 (0.1%) indeterminate cytology fine-needle aspiration samples; 5/5 resected fusion-positive nodules were HTT on surgical pathology.

conclusionsThis study demonstrates that GLIS rearrangements, particularly PAX8-GLIS3, are highly prevalent in HTT but not in PTC. The fusions lead to overexpression of GLIS, upregulation of extracellular matrix genes, and deposition of collagens, which is a characteristic histopathologic feature of HTT. Due to unique genetic mechanisms and an indolent behavior, it is proposed to rename this tumor as "GLIS-rearranged hyalinizing trabecular adenoma."

Indexed as

Gene RearrangementAdultAgedAged, 80 and overBiopsy, Fine-NeedleDNA-Binding ProteinsExomeFalse Positive ReactionsFemaleGenome-Wide Association StudyGenomicsHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryMaleMiddle AgedDNA-Binding ProteinsGLIS3 protein, humanPAX8 protein, humanPAX8 Transcription FactorRepressor ProteinsTrans-ActivatorsGLIS1GLIS3hyalinizing trabecular tumorthyroid

Identifiers

PMID30648929
PMCPMC6389773
OpenAlexW2910943264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.